 |
|
 |
- May 17, 2008 |
|
|
Welcome to the #1 online source of information for Diabetes Specialists! An international online community of more than 10,000 Diabetes Specialists.
CME on Diabetes is a website built to transmit top-level CME conferences given by international experts in endocrinology, insulin resistance, prediabetes, metabolic syndrome and type 2 diabetes. More than 2.6 million slides have been viewed since the website launch. Thank you for your continued support and commitment!
|
|
|
| Presentation |
|
"Treating Type 2 Diabetes Patients to Target"Dr. Lawrence A. Leiter (biography)
English - 2002-03-07 - 42 minutes
|
 | (52 slides) |
Summary :
This presentation is an excellent source of information on the guidelines used when treating patients with type 2 diabetes.
Learning objectives :
Upon this presentation, participant should be able to:
-List target glucose, BP and lipid level in patients with type 2 diabetes;
-Review recommended schedule of monitoring;
-Recognize the importance of achieving target level;
-Discuss treatment strategies for glucose, BP and lipids.
Bibliographic references :
Effect of wheat bran on glycemic control and risk factors for
cardiovascular disease in type 2 diabetes.
Jenkins DJ, Kendall CW, Augustin LS, Martini MC, Axelsen M, Faulkner D,
Vidgen E, Parker T, Lau H, Connelly PW, Teitel J, Singer W, Vandenbroucke
AC, Leiter LA, Josse RG.
Clinical Nutrition and Risk Factor Modification Center, St. Michael's
Hospital, Toronto, Ontario, Canada. cyril.kendall@utoronto.ca
OBJECTIVE: Cohort studies indicate that cereal fiber reduces the risk of
diabetes and coronary heart disease (CHD). Therefore, we assessed the
effect of wheat bran on glycemic control and CHD risk factors in type 2
diabetes. RESEARCH DESIGN AND METHODS: A total of 23 subjects with type 2
diabetes (16 men and 7 postmenopausal women) completed two 3-month phases
of a randomized crossover study. In the test phase, bread and breakfast
cereals were provided as products high in cereal fiber (19 g/day
additional cereal fiber). In the control phase, supplements were low in
fiber (4 g/day additional cereal fiber). RESULTS: Between the test and
control treatments, no differences were seen in body weight, fasting blood
glucose, HbA(1c), serum lipids, apolipoproteins, blood pressure, serum
uric acid, clotting factors, homocysteine, C-reactive protein, magnesium,
calcium, iron, or ferritin. LDL oxidation in the test phase was higher
than that seen in the control phase (12.1 +/- 5.4%, P < 0.034). Of the
subjects originally recruited, more dropped out of the study for health
and food preference reasons from the control phase (16 subjects) than the
test phase (11 subjects). CONCLUSIONS: High-fiber cereal foods did not
improve conventional markers of glycemic control or risk factors for CHD
in type 2 diabetes over 3 months. Possibly longer studies are required to
demonstrate the benefits of cereal fiber. Alternatively, cereal fiber in
the diet may be a marker for another component of whole grains that
imparts health advantages or a healthy lifestyle.
Diabetes Care 2002 Sep;25(9):1522-8
|
|
|
|
|
|
| Search our website |
 |
| |
Would you like to know more about insulin resistance? Are you looking for information pertaining to Type 2 Diabetes? You can find what you are looking for in over 2000 references available on CMEonDiabetes. |
| |
|
|
| Social |
|
| |
Let others know about this presentation.
|
|
|
|
